Pulsed Electromagnetic Field Treatment With Dementia Patients

Inclusion Criteria:

1. Age ≥ 50 years 2.2. Patients diagnosed with mild to moderate AD/ADRD includingAlzheimer's disease, Lewy body dementia, and Vascular dementia - defined as a globalCDR of 0.5 or 1 at baseline.

2. At least an eighth grade of educational achievement 4. If female, post-menopausal.

3. MMSE score between 16 and 26 (inclusive) 6. Capable of providing consent orhaving a surrogate (e.g., spouse, family member) capable of providing consent ifparticipant lacks consent capacity 7. Able and willing to comply with the protocol

4. If the participant is receiving a cholinesterase inhibitor and/or memantine, suchmedication has been prescribed for at least 3 months prior to screening and the doseis stable for at least 60 days prior to screening (that dose needs to be maintainedthroughout the period of this study) 10. Physical clearance for study participationas evaluated by the clinician

Exclusion Criteria:

1. The patient lacks capacity to consent to study participation and no surrogate isavailable to provide consent

2. The patient does not have a study partner who would be available for interview

3. History of epileptic seizures or epilepsy

4. Has Frontotemporal Dementia

5. Currently taking medication that lowers the seizure threshold, excluding bloodthinners

6. Is currently taking anti-amyloid monoclonal antibodies (past treatment is allowed iftermination of treatment occurred at least 3 months prior to the baseline visit).

7. Presence of depression, bipolar disorder, a psychotic disorder, or any otherneurological or psychiatric condition (whether now or in the past), which theInvestigator finds as interfering with the study

8. Severe agitation that would interfere with study procedures

9. Alcoholism or substance use disorder as defined by Diagnostic and Statistical Manualof Mental Disorders, Fifth Edition (DSM-5) within last 5 years (addicted more thanone year and or in remission less than 3 years) or severe sleep deprivation

10. Major surgery (defined as any major abdominal, vascular or thoracic surgeryrequiring general anesthesia and resulting in a period of >1 week hospitalization)within 4 weeks

11. Head anatomy that interferes with the fit of the treatment device

12. Participation in another clinical trial within the previous 30 days

13. Metal implants in the head, (i.e., cochlear implants, implanted brain stimulatorsand neurostimulators, aneurysm clips) with the exception of metal implants in mouth

14. Criteria to exclude participants from the blood draw study:

Any condition that may significantly increase risks associated with blood draws